Effect of recombinant αspi_sub1spii_sub -antitrypsin Fc-fused (aat-fc) protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 65-71

  Lee, Siyoung ^a   Lee, Youngmin ^b   Hong, Kwangwon ^a   Hong, Jaewoo ^a   Bae, Suyoung ^a   Choi, Jida ^a   Jhun, Hyunjhung ^a   Kwak, Areum ^a   Kim, Eunsom ^a   Jo, Seunghyun ^a   Dinarello, Charles A ^c   Kim, Soohyun ^a  

^a Konkuk University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CYTOKINE; ELASTASE; HYBRID PROTEIN; IMMUNOGLOBULIN G1; INTERLEUKIN 6; PROTEIN A; PROTEIN FC; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AAT GENE; AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MACROPHAGE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ALPHA 1-ANTITRYPSIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; CELL LINE; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; PANCREATIC ELASTASE; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877764142     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00308     Document Type: Article

References (38)

1. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. (2005) Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. U. S. A. 102:12153-8.
2. Song S, et al. (2004) Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther. 11:181-6.
3. Lu Y, et al. (2006) Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum. Gene Ther. 17:625-34.
4. Shahaf G, et al. (2011) Alpha-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol. Med. 17:1000-11.
5. Zhang B, et al. (2007) Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes. 56:1316-23.
6. Lewis EC, et al. (2008) Alpha1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl. Acad. Sci. U. S. A. 105:16236-41.
7. Koulmanda M, et al. (2008) Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl. Acad. Sci. U. S. A. 105:16242-7.
8. Pileggi A, et al. (2008) Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts. Transplant. Proc. 40:457-8.
9. Lisowska-Myjak B, Pachecka J, Antoniewicz B, Krawczyk A, Jozwik A. (1995) Alpha-1-antitrypsin, albumin and whole protein in meconium and stools during the first days of life in the neonate [in Polish]. Pediatr. Pol. 70:819-26.
10. Sharma K, et al. (2005) Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics. 5:2648-55.
11. Lisowska-Myjak B, Pachecka J. (2003) Antigenic and functional levels of alpha-1-antitrypsin in serum during normal and diabetic pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 106:31-5.
12. Lisowska-Myjak B, Pachecka J, Kaczynska B, Miszkurka G, Kadziela K. (2006) Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence. Acta Diabetol. 43:88-92.
13. Hashemi M, Naderi M, Rashidi H, Ghavami S. (2007) Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus. Diabetes Res. Clin. Pract. 75:246-8.
14. Yaghmaei M, et al. (2009) Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus. Diabetes Res. Clin. Pract. 84:201-4.
15. Kueppers F, Briscoe WA, Bearn AG. (1964) Hereditary deficiency of serum alpha-Lantitrypsin. Science. 146:1678-9.
16. Eriksson S. (1964) Pulmonary emphysema and alpha1-antitrypsin deficiency. Acta. Med. Scand. 175:197-205.
17. Blanco I, Lara B, de Serres F,(2011) Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet. J. Rare Dis. 6:14.
18. Cox DW, Woo SL, Mansfield T. (1985) DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature. 316:79-81.
19. Carroll TP, et al. (2010) Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency. J. Immunol. 184:4538-46.
20. Nita I, Hollander C, Westin U, Janciauskiene SM. (2005) Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir. Res. 6:12.
21. Al-Omari M, et al. (2011) Acute-phase protein alpha1-antitrypsin inhibits neutrophil calpain I and induces random migration. Mol. Med. 17:865-74.
22. Subramaniyam D, et al. (2008) TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int. J. Biochem. Cell Biol. 40:258-71.
23. Janciauskiene S, et al. (2008) Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro. Am. J. Respir. Cell Mol. Biol. 39:631-7.
24. Ryu CJ, Padlan EA, Jin BR, Yoo OJ, Hong HJ. (1996) A humanized antibody with specificity for hepatitis B surface antigen. Hum. Antibodies Hybridomas. 7:113-22.
25. Eden E, et al. (1997) Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency. Am. J. Respir. Crit. Care Med. 156:68-74.
26. Griffith ME, Lovegrove JU, Gaskin G, Whitehouse DB, Pusey CD. (1996) C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol. Dial. Transplant. 11:438-43.
27. King MA, et al. (1996) Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology. 199:137-41.
28. Ma H, et al. (2010) Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease. Diabetologia. 53:2198-204.
29. Toldo S, et al. (2011) Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 51:244-51.
30. Marcondes AM, et al. (2011) Inhibition of IL-32 activation by alpha-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model. Blood. 118:5031-9.
31. Tawara I, et al. (2012) Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. U. S. A. 109:564-9.
32. Kalis M, Kumar R, Janciauskiene S, Salehi A, Cilio CM. (2010) Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells. Islets. 2:185-9.
33. Kuttler B, et al. (2007) Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats. J. Cell Mol. Med. 11:868-80.
34. Heywood DM, Mansfield MW, Grant PJ. (1996) Levels of von Willebrand factor, insulin resistance syndrome, and a common vWF gene polymorphism in non-insulin-dependent (type 2) diabetes mellitus. Diabet. Med. 13:720-5.
35. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS. (1995) Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance. Diabetologia. 38:617-22.
36. Lisowska-Myjak B, Sygitowicz G, Wolf B, Pachecka J. (2001) Serum alpha-1-antitrypsin concentration during normal and diabetic pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 99:53-6.
37. Sandstrom CS, et al. (2008) An association between type 2 diabetes and alpha-antitrypsin deficiency. Diabet. Med. 25:1370-3.
38. Talmud PJ, et al. (2003) Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler. Thromb. Vasc. Biol. 23:644-9.